Excelsior Sciences

Round
excelsiorsci.com Biotech & Healthcare New York, United States 11–50 employees
Total Funding $165M
Latest Round $95M Round
Last Announced Dec 3, 2025
Investors 8 Backers
Decision Makers Profile Active

About Excelsior Sciences

Excelsior Sciences leverages blocc chemistry — automated, AI-friendly small molecule synthesis — to accelerate drug discovery and scale from molecule to manufacturing.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Round
Global Headquarters New York, United States
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website excelsiorsci.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @foley_mfoley
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $95,000,000 · Round

    fundraisingfox.com

  2. Capital Raise

    Raised $70,000,000 · Series-A

    Backed by Deerfield

Investors & Backers

8
Deerfield
Lead
Cornucopian Capital
Eli Lilly
Empire State Development
Illinois Ventures
Khosla Ventures
Massachusetts Institute of Technology (MIT)
Sofinnova Partners

Funding History

2 Rounds
Round equity · Dec 3, 2025
Series-A equity · Dec 3, 2025

Round backers: Deerfield

Founders & Leadership

6

Bartosz Grzybowski

Founder

Work email & phone locked Unlock →

Brian Goldman

Vice President AI And Data Sciences

Work email & phone locked Unlock →

Jana Jensen

Founder

Work email & phone locked Unlock →

Marc Feiglin

CTO & Head Corporate Development

Work email & phone locked Unlock →

Martin Burke

Founder

Work email & phone locked Unlock →

Michael Foley

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts